Fed. Circ. Won't Revive Parkinson's Drug Patent
The Federal Circuit has backed a lower court's finding that a UCB Inc. patent tied to Parkinson's disease drug Neupro is invalid, handing a win to patent challengers Actavis Laboratories UT...To view the full article, register now.
Already a subscriber? Click here to view full article